In silico modeling predicts drug sensitivity of patient-derived cancer cells.

Pingle SC, Sultana Z, Pastorino S, Jiang P, Mukthavaram R, Chao Y, Bharati IS, Nomura N, Makale M, Abbasi T, Kapoor S, Kumar A, Usmani S, Agrawal A, Vali S, Kesari S. In silico modeling predicts drug sensitivity of patient-derived cancer cells. J Transl Med. 2014 May 21; 12:128.

View in: PubMed

subject areas

Antineoplastic Agents
Cell Line, Tumor
Computer Simulation
Drug Screening Assays, Antitumor
Humans
Retrospective Studies

authors with profiles

Sandra Pastorino, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support